Company: NIVFW
Filing Date: 2025-09-18
Form Type: F-1
Source: 0001213900-25-088927
Chunk: 140

Company: NewGenIvf Group Ltd
Filing Date: 2025-09-18
Form: F-1
Chunk 140
---
 of operations of the accounting acquirer will become the historical financial statements of the Company,
and the accounting acquirer’s assets, liabilities and results of operations will be consolidated with the Company beginning on the
acquisition date. The Legacy NewGenIvf was the legal acquiree but deemed to be the accounting acquirer. The Company was the legal acquirer
but deemed to be the accounting acquiree in the reverse merger. The historical financial statements prior to the acquisition are those
of the accounting acquirer (Legacy NewGenivf). After completion of the Merger Transaction, the Company’s consolidated financial
statements include the assets and liabilities, the operations and cash flow of the accounting acquirer. Any excess of the value of shares
issued by the Company over the net book value of the accounting acquirer will be recognized as a reduction to equity (APIC).

<div align='center'>82</div>

Revenue recognition

The Company adopted ASC Topic
606, Revenue from Contracts with Customers. The Company derives revenue principally from provision of In vitro fertilization (“IVF”)
treatment and surrogacy and ancillary caring services. Revenue from contracts with customers is recognized using the following five steps:

| (1) | identify its contracts with customers; |

| (2) | identify its performance obligations under those contracts; |

| (3) | determine the transaction prices of those contracts; |

| (4) | allocate the transaction prices to its performance obligations in those contracts; and |

| (5) | recognize revenue when each performance obligation under those contracts is satisfied. Revenue is recognized when promised services are transferred to the client in an amount that reflects the consideration expected in exchange for those services. |

The Company enters into verbal
agreements with its customers that outline the rights, responsibilities, and obligations of each party. The agreements also identify the
scope of services, service fees, and payment terms. Agreements are acknowledged and consent forms are signed by the customers prior to
each promised service or bundle of services that are inter dependent. All the contracts have commercial substance, and it is probable
that the Company will collect considerations from its customers for service component as settlement is predominantly required prior to
performance of the promised service.

The Company derives its revenues
from two sources: (1) revenue from IVF treatment, and (2) revenue from surrogacy and ancillary caring services.

Revenue from IVF treatment

In vitro fertilization (“IVF”)
treatment is an assisted reproductive technique where eggs and sperm are collected